Germany · Delayed Price · Currency is EUR Pure Foods Tasmania Statistics
Total Valuation
FRA:C9CB has a market cap or net worth of EUR 2.61 million. The enterprise value is 5.28 million.
| Market Cap | 2.61M |
| Enterprise Value | 5.28M |
Important Dates
The last earnings date was Monday, December 1, 2025.
| Earnings Date | Dec 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 140.43M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +18.53% |
| Shares Change (QoQ) | -1.50% |
| Owned by Insiders (%) | 25.78% |
| Owned by Institutions (%) | 4.27% |
| Float | 49.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.91 |
| PB Ratio | 0.75 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.36 |
| EV / Sales | 1.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.40, with a Debt / Equity ratio of 0.93.
| Current Ratio | 0.40 |
| Quick Ratio | 0.22 |
| Debt / Equity | 0.93 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.22 |
Financial Efficiency
Return on equity (ROE) is -38.00% and return on invested capital (ROIC) is -13.45%.
| Return on Equity (ROE) | -38.00% |
| Return on Assets (ROA) | -11.29% |
| Return on Invested Capital (ROIC) | -13.45% |
| Return on Capital Employed (ROCE) | -34.69% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.34 |
| Inventory Turnover | 4.25 |
Taxes
| Income Tax | -476,251 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.33% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +33.33% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 57.64 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:C9CB had revenue of EUR 2.89 million and -1.57 million in losses. Loss per share was -0.01.
| Revenue | 2.89M |
| Gross Profit | 324,018 |
| Operating Income | -1.52M |
| Pretax Income | -2.04M |
| Net Income | -1.57M |
| EBITDA | -1.15M |
| EBIT | -1.52M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 609,348 in cash and 3.25 million in debt, giving a net cash position of -2.64 million.
| Cash & Cash Equivalents | 609,348 |
| Total Debt | 3.25M |
| Net Cash | -2.64M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.49M |
| Book Value Per Share | 0.02 |
| Working Capital | -2.25M |
Cash Flow
| Operating Cash Flow | -927,442 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 11.23%, with operating and profit margins of -52.84% and -54.37%.
| Gross Margin | 11.23% |
| Operating Margin | -52.84% |
| Pretax Margin | -70.88% |
| Profit Margin | -54.37% |
| EBITDA Margin | -39.94% |
| EBIT Margin | -52.84% |
| FCF Margin | n/a |
Dividends & Yields
FRA:C9CB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.53% |
| Shareholder Yield | -18.53% |
| Earnings Yield | -60.07% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:C9CB has an Altman Z-Score of -1.67 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.67 |
| Piotroski F-Score | 4 |